Exact Mass: 300.01094880000005
Exact Mass Matches: 300.01094880000005
Found 209 metabolites which its exact mass value is equals to given mass value 300.01094880000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cinnavalininate
Cinnavalininate is an intermediate in the tryptophan metabolic pathway [Kegg: C05640]. It is generated from 3-hydroxyanthranilate via the enzyme catalase (EC:1.11.1.6). [HMDB] Cinnavalininate is an intermediate in the tryptophan metabolic pathway [Kegg: C05640]. It is generated from 3-hydroxyanthranilate via the enzyme catalase (EC:1.11.1.6). Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis[1].
Tazobactam
Tazobactam is only found in individuals that have used or taken this drug.It is a antibacterial penicillin derivative which inhibits the action of bacterial beta-lactamases.Tazobactam broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CG - Beta-lactamase inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor D004791 - Enzyme Inhibitors Tazobactam (CL-298741) is a potent β-lactamases inhibitor and penicillin antibiotic. Tazobactam has antibacterial activity. Tazobactam can be used for pneumonia research[1][2].
Mumefural
Mumefural is isolated from fruit juice concentrate of Prunus mume (Japanese apricot Isolated from fruit juice concentrate of Prunus mume (Japanese apricot)
Demethylwedelolactone
Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
Indole-2-carboxylic acid, 5-(bis(2-chloroethyl)amino)-
Itanoxone
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
UXN2KXV8BB
Demethylwedelolactone is a member of coumestans. Demethylwedelolactone is a natural product found in Sphagneticola calendulacea, Eclipta alba, and other organisms with data available. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
Emodic acid
Emodicacid is a member of anthracenes.
Norwedelolactone
Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
3(2-Chlorophenyl)-7-ethoxycoumarin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.294 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.292
STA-0DC (TENTATIVE)
TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; BASE PEAK ARISES FROM CO-ELUTING COMPOUND!!!!!; Extracted (without noise removal) from ZUE_N: mz299_02_rt8_95_HCD60_STA-0DC; CONFIDENCE Tentative identification: best match only (Level 3)
4-Phenyl-5-benzyl-dithiol-(1,2)-thion-(3)|5-Benzyl-4-phenyl-[1,2]dithiol-3-thion|5-benzyl-4-phenyl-[1,2]dithiol-3-thione|5-benzyl-4-phenyl-[1,2]dithiole-3-thione
3-(3-chloro-1,2-dihydroxypropyl)-8-hydroxy-6-methoxyisochromen-1-one
Sodium phosphonatoformate hexahydrate
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
(4-Chlorophenyl)(4-(trifluoromethoxy)phenyl)methanone
C14H8ClF3O2 (300.01648939999995)
3-bromo-4-(2,2-dimethylpropanoyloxy)benzoic acid
C12H13BrO4 (299.99971580000005)
3-bromo-4-(oxan-4-yloxy)benzoic acid
C12H13BrO4 (299.99971580000005)
5-(4-methylphenyl)sulfonyl-2-methylsulfanyl-1,3-thiazol-4-amine
3,6-Di(2-thienyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione
Sulazepam
C16H13ClN2S (300.04879280000006)
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
1-(2-Bromo-4-nitrophenyl)piperidin-4-ol
C11H13BrN2O3 (300.01094880000005)
Methyl 2-chloro-3-[2-chloro-4-(trifluoromethyl)phenyl]propanoate
C11H9Cl2F3O2 (299.99316699999997)
2-chloro-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
C13H8ClF3N2O (300.02772239999996)
5-exo,6-endo,7-exo,8-endo-5,6,7,8-tetra(chloromethyl)-bicyclo[2.2.2]oct-2-ene
Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt
C8H11N2Na3O6 (300.03101860000004)
2-phenyl-3-sulfanylidene-4,6,7,8-tetrahydrocyclopenta[2,3]thieno[2,4-b]pyrimidin-1-one
3-bromo-N,N-diethyl-5-nitrobenzamide
C11H13BrN2O3 (300.01094880000005)
2-(2-imino-1,3-thiazolidin-3-yl)-1-phenylethanone,hydrobromide
C11H13BrN2OS (299.99319080000004)
2-NITRO-1-(2-PYRIDYLTHIO)-4-(TRIFLUOROMETHYL)BENZENE
7-chloro-2,4-bis(trifluoromethyl)-1,8-naphthyridine
3-(4-CHLOROPHENYL)-5-METHYLTHIO-1-PHENYL-1H-PYRAZOLE
C16H13ClN2S (300.04879280000006)
2-[2-[(4-CHLOROPHENYL)SULFONYL]ETHYL]CYCLOHEXAN-1-ONE
sodium,4-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]benzenesulfonate
2-(Boc-amino)-5-bromoisonicotinaldehyde
C11H13BrN2O3 (300.01094880000005)
4-(METHYLTHIO)-2-(([2-(METHYLTHIO)-3-PYRIDYL]CARBONYL)AMINO)BUTANOIC ACID
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate hydrochloride
diethyl 2-bromobenzene-1,4-dicarboxylate
C12H13BrO4 (299.99971580000005)
2-Bromo-4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridine
(6-bromo-1H-pyrrolo[2,3-b]pyridin-1-yl)(phenyl)methanone
1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE, 1-[(4-METHYLPHENYL)SULFONYL]-
methyl 1-(3,4-dichlorophenyl)-4-oxocyclohexane-1-carboxylate
isobromindione
M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion C26170 - Protective Agent > C921 - Uricosuric Agent
Methanone, (5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl-
2-BENZO[1,3]DIOXOL-5-YL-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE
ethyl 4-phenyl-5-(trifluoromethyl)thiophene-2-carboxylate
N-(2-BROMO-6-NITROPHENYL)-N-ISOPROPYLACETAMIDE
C11H13BrN2O3 (300.01094880000005)
3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)PYRIDIN-2-AMINE
3-ALLYL-5-(3-ETHYL-4-METHYL-2-THIAZOLINYLIDENE)RHODANINE
S-Acetylthioglycolic acidpentafluorophenyl ester
C10H5F5O3S (299.98795600000005)
4-Iodo-1-(phenylMethoxy)-1H-pyrazole
C10H9IN2O (299.97596139999996)
1-Bromo-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]benzene
(5-BROMO-1,3-PHENYLENE)BIS(TRIMETHYLSILANE)
C12H21BrSi2 (300.03650860000005)
Methyl-2-(5-brompyridin-3-yl)norleucinat
C12H17BrN2O2 (300.04733219999997)
4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID
C12H7F3N2O4 (300.03578980000003)
(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine
1-(4-Iodo-5-methyl-1H-pyrrolo[2,3-b]pyridin-1-yl)ethanone
C10H9IN2O (299.97596139999996)
tert-butyl 5-chloro-3-(chloromethyl)pyrrolo[2,3-b]pyridine-1-carboxylate
oxolan-2-ylmethyl 5-bromo-2-hydroxybenzoate
C12H13BrO4 (299.99971580000005)
4-phenyl-1-(trideuteriomethyl)pyridin-1-ium,iodide
(3-Bromo-4-methylphenoxy)(tert-butyl)dimethylsilane
1-[(4-NITROPHENYL)SULFONYL]PYRROLIDINE-2-CARBOXYLIC ACID
C11H12N2O6S (300.04160520000005)
1-[4-(5-bromopentoxy)-2-hydroxyphenyl]ethanone
C13H17BrO3 (300.03609919999997)
2-[3-chloro-4-(trifluoromethyl)phenyl]benzoic acid
C14H8ClF3O2 (300.01648939999995)
2-(4-bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C12H15BBrFO2 (300.03324319999996)
4-CHLORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID
C14H8ClF3O2 (300.01648939999995)
(2S)-1-(3-nitrophenyl)sulfonylproline
C11H12N2O6S (300.04160520000005)
3-[2-carboxyethylsulfanyl(phenyl)methyl]sulfanylpropanoic acid
5-(4-CHLOROPHENYL)-3-METHYLTHIO-1-PHENYL-1H-PYRAZOLE
C16H13ClN2S (300.04879280000006)
2-Bromomethyl-4-fluorophenylboronic acid neopentyl glycol ester
C12H15BBrFO2 (300.03324319999996)
5-Bromo-2-fluorophenylboronic acid pinacol ester
C12H15BBrFO2 (300.03324319999996)
TERT-BUTYL (5-BROMOPYRIDIN-2-YL)(ETHYL)CARBAMATE
C12H17BrN2O2 (300.04733219999997)
methyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(4-methoxyphenyl)penta-2,4-dienoate
4-(2,3-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC
2-(2-NITROPHENYLTHIO)ISOINDOLINE-1,3-DIONE
C14H8N2O4S (300.02047680000004)
2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoic acid
2-(4-METHOXY-PHENYL)-5-THIOPHEN-2-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID
1-benzyl-5-(4-chlorophenyl)-1H-imidazole-2-thiol
C16H13ClN2S (300.04879280000006)
2-(1,3,4-Oxadiazol-2-yl)phenyl 4-chlorobenzenecarboxylate
2-chloro-N-[3-[(2-chlorophenyl)methyl]-2-thiazolylidene]acetamide
C12H10Cl2N2OS (299.98908700000004)
3-chloro-N-[5-(3-pyridinyl)-1,3,4-oxadiazol-2-yl]benzamide
6-Hydroxy-11-methyl-13-(trifluoromethyl)-8-thia-3,10-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5,10,12-pentaen-4-one
5,6-Bis[(2-hydroxyethyl)sulfanyl]benzimidazole-4,7-quinone
3-(3-Chloro-1,2-dihydroxypropyl)-8-hydroxy-6-methoxyisochromen-1-one
2,2-Piperazine-1,4-diylbisethanesulfonate
C8H16N2O6S2-2 (300.04497560000004)
(2R,3S,5R,6S)-4-{[amino(iminio)methyl]amino}-2,3,5,6-tetrahydroxycyclohexyl phosphate
C7H15N3O8P- (300.05967400000003)
N-acetyl-D-galactosamine 6-O-sulfate
C8H14NO9S- (300.03892540000004)
2-Amino-6-chloro-4-(3-sulfonatoanilino)-1,3,5-triazine
C9H7ClN5O3S- (299.99581220000005)
N-acetyl-D-glucosamine 6-sulfate(1-)
C8H14NO9S- (300.03892540000004)
N-acetyl-beta-D-galactosamine 4-O-sulfate
C8H14NO9S- (300.03892540000004)
alpha-N-acetyl-D-glucosamine 3-sulfate
C8H14NO9S- (300.03892540000004)
N-acetyl-beta-D-galactosamine 6-sulfate(1-)
C8H14NO9S- (300.03892540000004)
3-(3,4-dichlorophenyl)-N-(4,5-dihydro-1,3-thiazol-2-yl)acrylamide
C12H10Cl2N2OS (299.98908700000004)
N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-pyridinecarboxamide
4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
6-Oxo-1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid
C14H8N2O4S (300.02047680000004)
An arenesulfonic acid that is 1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid substituted by an oxo group at position 6.
7-[(4-Acetylphenoxy)methyl]-5-thiazolo[3,2-a]pyrimidinone
2-[[Acetamido(sulfanylidene)methyl]amino]-5-ethyl-3-thiophenecarboxylic acid ethyl ester
5-[(6-Hydroxy-4-oxo-1-benzopyran-3-yl)methylidene]-1,3-diazinane-2,4,6-trione
2-[(2,2-dichloro-3,3-dimethylcyclopropyl)methylthio]-1H-benzimidazole
4-(5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid
N3-(4-chlorophenyl)-4-(trifluoromethyl)nicotinamide
C13H8ClF3N2O (300.02772239999996)
5-(Methylsulfanyl)-2-(thiophen-2-yl)-3-(trifluoromethyl)pyridine-4-carbonitrile
Tazobactam
A member of the class of penicillanic acids that is sulbactam in which one of the exocyclic methyl hydrogens is replaced by a 1,2,3-triazol-1-yl group; used (in the form of its sodium salt) in combination with ceftolozane sulfate for treatment of complicated intra-abdominal infections and complicated urinary tract infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CG - Beta-lactamase inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor D004791 - Enzyme Inhibitors Tazobactam (CL-298741) is a potent β-lactamases inhibitor and penicillin antibiotic. Tazobactam has antibacterial activity. Tazobactam can be used for pneumonia research[1][2].
Cinnabarinic acid
Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis[1].
phosphatidylglycerol (18:2/16:1)
A phosphatidylglycerol 34:3 in which the acyl group at position 1 contains 18 carbons and two double bonds while that at position 2 contains 16 carbons and 1 double bond.
6,13-dihydroxy-5-methoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione
3-[(2r)-2-chloro-3-hydroxypropyl]-5,8-dihydroxy-6-methoxyisochromen-1-one
(3r)-7-bromo-6,8-dihydroxy-3-propyl-3,4-dihydro-2-benzopyran-1-one
C12H13BrO4 (299.99971580000005)
5-(1,2-dihydroxyethyl)-2,6,10,12-tetrahydroxy-4,7-dioxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-trien-3-one
(4s,7s)-4,7-bis(2-methylpropyl)-1,2,3,5,6-pentathiepane
7-bromo-6,8-dihydroxy-3-propyl-3,4-dihydro-2-benzopyran-1-one
C12H13BrO4 (299.99971580000005)
4,6,13,14-tetrahydroxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one
(3s,5r,6s)-3-bromo-5-chloro-6-[(1e)-2-chloroethenyl]-2,2,6-trimethyloxane
(3s,5r,6r)-3-bromo-5-chloro-6-[(1e)-2-chloroethenyl]-2,2,6-trimethyloxane
methyl 2-[(4r)-7-bromo-2-methyl-1-oxo-3h,4h-pyrrolo[1,2-a]pyrazin-4-yl]acetate
C11H13BrN2O3 (300.01094880000005)
methyl 2-{7-bromo-2-methyl-1-oxo-3h,4h-pyrrolo[1,2-a]pyrazin-4-yl}acetate
C11H13BrN2O3 (300.01094880000005)
3-bromo-5-chloro-6-[(1e)-2-chloroethenyl]-2,2,6-trimethyloxane
3-(2-chloro-3-hydroxypropyl)-5,8-dihydroxy-6-methoxyisochromen-1-one
7-bromo-6,8-dimethoxy-3-methyl-3,4-dihydro-2-benzopyran-1-one
C12H13BrO4 (299.99971580000005)
7-(methyldisulfanyl)-3-phenylcyclohepta[b]furan-2-one
(2s)-2-{2-[(5-formylfuran-2-yl)methoxy]-2-oxoethyl}-2-hydroxybutanedioic acid
(2r)-2-[(1-hydroxyethylidene)amino]-3-{[(1z)-1-(hydroxyimino)-2-phosphonoethyl]sulfanyl}propanoic acid
C7H13N2O7PS (300.01810780000005)
(3r)-7-bromo-6,8-dimethoxy-3-methyl-3,4-dihydro-2-benzopyran-1-one
C12H13BrO4 (299.99971580000005)